- First patient enrolled in trial evaluating Tome Clearing Treatment for once-weekly acne care.
- Company targets commercial launch for this second product candidate in H1 2027.
?? Positive AI Sentiment (+2.5 / 10)
Ticker archive · $DRMA
$DRMA Filing Signals & Market Reactions
Delayed, SEO-crawlable recaps of AI-scored catalysts for $DRMA — including observed post-filing price moves. Live streaming stays exclusive to VIP.